Acumen Pharmaceuticals, Inc. (ABOS) vs Molecular Partners AG Sponsored ADR (MOLN)
Acumen Pharmaceuticals, Inc. and Molecular Partners AG Sponsored ADR are both Biotechnology companies. Acumen Pharmaceuticals, Inc. and Molecular Partners AG Sponsored ADR are of similar size ($161.6M and $160.5M). Across the 11 metrics below, Molecular Partners AG Sponsored ADR leads on 10 and Acumen Pharmaceuticals, Inc. on 1.
Valuation
Profitability
| Metric | ABOS | MOLN | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (120.50%) | (63.89%) | (57.72%) |
| Return on assets | (72.97%) | (52.73%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack